| Document |
Document Title |
|
WO/2013/089188A1 |
An optically active bicyclic compound is efficiently produced by performing optical resolution using an optically active amine.
|
|
WO/2013/083513A1 |
A continuous process for the preparation of a mixture of cyclohexanone and cyclohexanol, said process comprising: a) oxidizing cyclohexane, in an oxidation section, without a transition metal- containing catalyst, in the presence of an o...
|
|
WO/2013/083512A1 |
A continuous process for the preparation of a mixture of cyclohexanone and cyclohexanol, said process comprising: a) oxidizing, in an oxidation section, cyclohexane in the presence of an oxygen-containing gas, without a transition metal-...
|
|
WO/2013/079876A1 |
The invention relates to a compound having general formula (I), as well as a composition comprising at least said compound having formula (I) and the uses thereof in perfumery.
|
|
WO/2013/079708A1 |
The present invention relates to a compound of formula (I): wherein: X is methyl or chlorine; R1 is methyl or chlorine; R2 is hydrogen, methyl, ethyl, n-propyl, cyclopropyl, vinyl, ethynyl, fluorine, chlorine, bromine, methoxy, ethoxy or...
|
|
WO/2013/069898A1 |
The present invention relates to a catalyst composition for hydrogenation reduction of phenol including palladium and a triplet compound of rare earth elements, and a method for preparing cyclohexanone comprising a step for forming cyclo...
|
|
WO/2013/071210A1 |
Described herein is a process for the synthesis of etonogestrel and desogestrel and intermediates used to form etonogestrel and desogestrel.
|
|
WO/2013/069261A1 |
A photovoltaic conversion element (10) has a construction wherein an electron transport layer (40), a conduction zone bottom end energy adjustment layer (50), a photovoltaic conversion layer (60) and a positive hole transport layer (70) ...
|
|
WO/2013/065922A1 |
The present invention relates to a pharmaceutical composition for preventing and treating an inflammatory disorder in the nervous system. According to the above-described present invention, a novel diphenylepropenone compound ((E)-3-(3,5...
|
|
WO/2013/061720A1 |
Provided are a material for a positive hole injection transport layer, and a production method therefor, whereby it is possible to form the positive hole injection transport layer by a solution application process, and to improve the lif...
|
|
WO/2013/059984A1 |
Disclosed are a new kind of derivative of methacryloyl-benzimidazol-one (thione), a preparation method for the compound, and the use of the compound as an anti-microbial drug. The compound has the structure as shown in the following gene...
|
|
WO/2013/060254A1 |
Disclosed are a new photoinitiator system of a combination of aromatic hydroxyl ketones and phosphoryl oxides, and an olefinic unsaturation-containing system that is radiation curable by light (UV-light or visible light or an equivalent ...
|
|
WO/2013/054998A1 |
The present invention relates to a novel chalcone derivative and to an anticancer composition comprising same as an active ingredient.
|
|
WO/2013/054325A1 |
The invention provides pentabromobenzyl moiety containing hydroxy-functional compounds which are useful as flame-retardants in flexible and rigid polyurethane foams and also in rigid polyisocyanurate foams. Processes for preparing the co...
|
|
WO/2013/054131A1 |
The present invention provides processes for the production of chiral compounds in a stereoisomeric excess. The present processes involve reacting a hydrometallated alkene compound with a compound comprising a conjugated -bond system und...
|
|
WO/2013/050365A1 |
The present invention relates to a new method for isolating ingenol (C20H28O5) from mixtures of diterpenoid esters and ingenol esters in a single step. Ingenol isolated by means of this method can be used as a precursor for the synthesis...
|
|
WO/2013/052148A1 |
Provided herein are geranylgeranylacetone derivatives and methods of using them.
|
|
WO/2013/052216A1 |
In a process for producing phenol, cyclohexylbenzene hydroperoxide is cleaved to produce a cleavage effluent stream comprising phenol and cyclohexanone and at least a portion of the cleavage effluent stream is fractionated to produce a f...
|
|
WO/2013/051765A1 |
The present invention relates to 1-(5-bromo-2-hydroxy-4-methoxyphenyl)ethanone, which has anti-inflammatory effects, and to a pharmaceutical composition containing same. The pharmaceutical composition exhibits anti-inflammatory effects a...
|
|
WO/2013/043609A1 |
Methods and systems for producing low methanol concentration acetone are provided. The method can include oxidizing and cleaving cumene to produce a crude acetone product. The crude acetone product can be neutralized in a neutralization ...
|
|
WO/2013/043272A1 |
In a process for producing phenol, a feed comprising cyclohexylbenzene hydroperoxide is contacted with a cleavage catalyst comprising a fluorinated acidic resin under cleavage conditions effective to convert at least a portion of the cyc...
|
|
WO/2013/042706A1 |
The present invention provides a rare metal-free active material able to obtain a secondary battery with high capacity and excellent cycle characteristics, and a secondary battery using this active material. The present invention is a ca...
|
|
WO/2013/043271A1 |
In a process for producing phenol, a feed comprising cyclohexylbenzene hydroperoxide is contacted with a cleavage catalyst comprising an acidic ionic liquid under cleavage conditions effective to cleave at least a portion of said cyclohe...
|
|
WO/2013/038136A1 |
Bi- and tri-aromatic compounds of the formula (I) wherein R1 to RIO and X are as defined, are Nox2 inhibitors that are useful as medicaments for the treatment of a disease or condition selected from: cardiovascular diseases, respiratory ...
|
|
WO/2013/037964A1 |
A compound of formula (I), a positional or structural isomer thereof, or a pharmaceutically acceptable base addition salt or acid addition salt thereof, use thereof as a medicament, in particular an anticancer medicament.
|
|
WO/2013/035674A1 |
The present invention provides a method for producing a 2-halo-1-(1-halocyclopropyl)ethanone represented by general formula (I), wherein a compound represented by general formula (II) is halogenated by being reacted with a sulfuryl halid...
|
|
WO/2013/030110A1 |
The invention relates to a method for producing a compound of formula (I) or a mixture comprising a compound of formula (I), comprising the following steps: dissolving an indanone of formula (II) in a solvent or in a mixture containing a...
|
|
WO/2012/177357A9 |
The present application relates to perfume raw materials, perfume delivery systems and consumer products comprising such perfume raw materials and/or such perfume delivery systems, as well as processes for making and using such perfume r...
|
|
WO/2013/026942A1 |
The invention provides combretastatin A-4 like compounds that are modified to have enhanced tubulin binding activity and in some embodiments the ability to promote accumulation in the vasculature undergoing angiogenesis (homing activity)...
|
|
WO/2013/024595A1 |
The photoelectric conversion element (10) has a structure in which an electron transportation layer (40), a photoelectric conversion layer (50), and a hole transportation layer (60) are sandwiched between a first electrode (30) and a sec...
|
|
WO/2013/020467A1 |
The present invention relates to the technical field of novel material in UV radiation free radical polymerization/curing and polymer electronic chemicals. Disclosed are a method for preparing a bis-aromatic ketone compound derived from ...
|
|
WO/2013/020966A1 |
The present disclosure relates to compounds to be used in a low dose in treatment of neurodegenerative diseases or disorders. It also relates to methods for treatment of a neurodegenerative diseases or disorders.
|
|
WO/2013/020204A1 |
Biodegradable polymeric nanoparticles comprising an inner core formed of a photodynamic agent capable of being activated to generate cytotoxic singlet oxygen are prepared. These nanoparticles have anti-cell proliferation activity and are...
|
|
WO/2013/018626A1 |
An object of the present invention is to provide a new method for producing an ALPHA-ketoaldehyde compound from a 2-oxo-primary alcohol compound. The present invention provides a method for producing an ALPHA-ketoaldehyde compound includ...
|
|
WO/2013/018876A1 |
To provide an organic electroluminescence device that emits blue light and is excellent in luminescence properties (in particular, external quantum yield), and provide an organic metal complex including xanthone in a ligand of the follow...
|
|
WO/2013/014486A1 |
A process for preparation of 2-(4-(4-chlorophenyl) cyclohex-l-enyl)-3,4-dihydronaphthalen- 1(2H)-one (V), key intermediate for synthesis of Atovaquone [I]. The process for preparation of compound(V) comprising of the steps of; i) Reactio...
|
|
WO/2013/010894A1 |
The present invention relates to phenylalkyl-substituted 2-[2-chloro-4-(4-chloro-phenoxy)-phenyl]-1 -[1,2,4]triazol-1-yl-ethanol compounds of formula I as defined in the description, and the N-oxides, and salts thereof, their preparation...
|
|
WO/2013/012203A2 |
The present invention relates to a method of preparing cumyl alcohol and a method of preparing phenol, acetone and alpha methyl styrene. According to the present invention, through a hydrogenation process for cumene hydroperoxide obtaine...
|
|
WO/2013/010885A1 |
The present invention relates to alkyl- and aryl-substituted 2-[2-chloro-4-(dihalo-phenoxy)-phenyl]-1-[1,2,4]triazol-1-yl
-ethanol compounds of formula 8I) as defined in the description, and the N-oxides, and salts thereof, processes and...
|
|
WO/2013/011115A1 |
The present invention relates to a method of obtaining radiopharmaceutical precursors, and in particular precursors to protected amino acid derivatives, which are used as precursors for production of radiolabelled amino acids for use in ...
|
|
WO/2013/008835A1 |
An organic light-emitting element comprising a first electrode, a second electrode, and a light-emitting layer disposed between the first electrode and the second electrode; wherein the light-emitting layer includes a host material, a fi...
|
|
WO/2013/010102A2 |
The present invention provides compositions and methods for the administration and targeted delivery, release and/or formation of a drug compound from a halogenated phenol starting compound of the present invention at site(s) within the ...
|
|
WO/2013/004476A1 |
The present invention relates to compounds of Formula (I), wherein the dotted line represents a carbon-carbon single or double bond and R represents a hydrogen atom or a methyl group; which are useful perfuming ingredients to impart odor...
|
|
WO/2013/001490A1 |
Disclosed are dihydrochaicone derivatives useful in the treatment of inflammatory and neuro-inflammatory diseases such as Alzheimer and Parkinson or conditions such as stroke. Both a and β carbons of the dihydrochaicone are hydroxylated...
|
|
WO/2012/173909A2 |
The invention provides a method for synthesizing 7-Acetyleno quinone methide compounds that is safe and inexpensive. The meod avoids the need for extremely cold reaction temperatures and unlike the prior art does not require any highly e...
|
|
WO/2012/172893A1 |
A hexafluoroacetone or a hydrate thereof can be produced with high yield by subjecting a 1-fluoro-4,4-bis(trifluoromethyl)-2,3,5-trioxolanyl ether compound represented by general formula (1) (wherein R represents an alkyl group having 1-...
|
|
WO/2012/174436A1 |
Disclosed are compounds which are nuclear receptor modulators that can act as antagonists to the androgen receptor, for example, a compound of Formula I: wherein R1 to R5 and X1 to X5 are as described herein, as well as pharmaceutically ...
|
|
WO/2012/170196A1 |
Partially fluorinated ketones are provided that include a terminal alkyl group having from 1 to 6 carbon atoms bonded to a carbonyl group and a hydrofluoroether moiety having from 2 to 4 carbon atoms that contains at least one hydrogen s...
|
|
WO/2012/169474A1 |
[Problem] To provide a method for producing a compound having excellent activity as an α2δ ligand. [Solution] This method for producing a compound or a salt thereof having the general formula (VI) via an iminium salt. [In the formula, ...
|
|
WO/2012/169468A1 |
Provided is a novel method for producing a cyclopentanone compound. The present invention is a method for producing a cyclopentanone compound represented by formula (I), comprising the steps of: reacting a compound represented by formula...
|
